Sign in
Not yet taking people in United StatesNo phase

Stanford-Lucidify EEG Delirium Study

Key facts

Who runs it
Stanford University
Where
Stanford, United StatesSee the site
Trial code
Status
Not yet recruiting
People taking part
80 people, planned
Started
1 Jun 2025
Planned end
30 May 2026
Type of study
Observational, 2 groups
Treatments tested
  • Electroencephalogram (EEG)
Record updated
31 May 2025

Who can take part

Age
55 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Age is 55 years or older
  • Clinical suspicion of delirium or subject at risk for delirium
  • Admitted to the Intensive Care Unit (ICU) or Oncology wards
  • Expected hospital stay is greater than one (1) day
  • Subject must be fluent in English

Who cannot take part

  • Subjects with a primary neurological or neurosurgical condition such as stroke, epilepsy, brain tumor, or witnessed seizures, Parkinson's disease, traumatic brain injury, or s/p craniectomy
  • Age is younger than 55 years
  • Active CNS substance abuse, intoxication, or withdrawal
  • Unarousable or unresponsive subjects with RASS <-3
  • Subject is blind, deaf, or unable to speak or understand English

Where in United States

  • Stanford Hospital and ClinicsStanford, United StatesContact: Derek O Pipolo, M.D.Not yet recruiting

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the effectiveness of the CGX/Lucidify EEG system in enabling physicians to detect delirium (confusion) in medically ill patients as early as possible in order to minimize the detrimental effects of delirium. The study will involve collecting EEG data through the CGX EEG system (a Research-grade 2-Channel EEG device) and applying the Lucidify EEG software algorithm to identify indicators and degree of delirium, obtain data regarding the amount and degree of patient's movement and activity throughout the day in order to detail delirium subtype, and obtain data regarding the quality of the sleep as it affects delirium severity and duration. By enhancing early detection, this research aims to improve patient outcomes and inform clinical decision-making.

The 2 groups in the trial

  • ICU Population

    Subjects admitted to the Intensive Care Unit (ICU)

    Treatment: Electroencephalogram (EEG)

  • Oncology Population

    Subjects admitted to oncology units with hematologic malignancies undergoing cellular therapies or hematopoietic stem cell transplants (e.g., stem cell and Chimeric Antigen Receptor T-cell (CAR-T) Therapy)

    Treatment: Electroencephalogram (EEG)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Stanford-Lucidify Delirium Monitoring Pilot Study
Record updated
31 May 2025